Paid Clinical Trials Huntington

Discover 122 paid clinical trials in Huntington, West Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 122

Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate ControlRandomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control

Recruiting

Sponsor:

CAMC Health System

Location:

Charleston WV

Code:

NCT02025465

Conditions

Atrial Fibrillation

Atrial Flutter

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Metoprolol

Diltiazem

Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)

Recruiting

Sponsor:

CAMC Health System

Location:

Charleston WV

Code:

NCT02742974

Conditions

Critical Illness

Trauma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FloTrac™ and EV1000™

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineA 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Huntington WV, Lexington KY, Cincinnati OH, Kingwood WVshow 73 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Huntington WV, Lexington KY, Morgantown WV, Sylvania OHshow 85 more

Code:

NCT06116682

Conditions

Lung Non-Small Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

The PEERLESS II StudyThe PEERLESS II Study

Recruiting

Sponsor:

Inari Medical

Location:

Charleston WV, Columbus OH, Cincinnati OH, Morgantown WVshow 45 more

Code:

NCT06055920

Conditions

Pulmonary Embolism

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FlowTriever System

Anticoagulation Agents

Colon Adjuvant Chemotherapy Based on Evaluation of Residual DiseaseColon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Recruiting

PHASE2

PHASE3

Sponsor:

NRG Oncology

Location:

Portsmouth OH, Charleston WV, Chillicothe OH, Parkersburg WVshow 670 more

Code:

NCT05174169

Conditions

Stage III Colon Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Signatera test

mFOLFOX6 3-6 month

CAPOX 3 month

mFOLFIRINOX

mFOLFOX6 6 month

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsEfficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Charleston WV, Pittsburgh PA, Gastonia NC, Charlotte NCshow 68 more

Code:

NCT05166889

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Tozorakimab

Placebo

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell HistiocytosisA Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Charleston WV, Columbus OH, Lexington KY, Dayton OHshow 78 more

Code:

NCT05828069

Conditions

Recurrent Langerhans Cell Histiocytosis

Refractory Langerhans Cell Histiocytosis

Eligibility Criteria

Sex: All

Age: 180 - 22

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Echocardiography

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerOsimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Portsmouth OH, Charleston WV, Chillicothe OH, Belpre OHshow 415 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims StudyMILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Huntington WV, Ashland KY, Charleston WV, Logan WVshow 1071 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression